Literature DB >> 1672579

Interaction between opiate subtype and alpha-2 adrenergic agonists in suppression of noxiously evoked activity of WDR neurons in the spinal dorsal horn.

K Omote1, L M Kitahata, J G Collins, K Nakatani, I Nakagawa.   

Abstract

Several studies have demonstrated synergistic antinociception following low-dose administration of morphine and alpha-2 adrenergic agonists at the spinal level. This study was carried out in order to identify the opiate subtypes that are likely to be involved in such synergistic suppression of noxiously evoked activity of wide-dynamic-range (WDR) neurons in the dorsal horn of the spinal cord. We also examined the effect of opiate antagonists and alpha-2 adrenergic antagonists on the suppression produced by opiate or alpha-2 adrenergic agonists. Extracellular activity of single WDR neurons in the spinal dorsal horn, which was evoked by a radiant heat stimulus (51 degrees C), was recorded in decerebrate, spinally transected cats. Agonists were administered spinally and antagonists intravenously. In the synergism study, ineffective doses of the moderately selective mu agonist morphine (25 micrograms), the delta agonist DADL (20 micrograms), and the selective delta agonist DPDPE (30 micrograms), when combined with an ineffective dose of the alpha-2 adrenergic agonist clonidine (5 micrograms) produced significant synergistic suppression of noxiously evoked WDR neuronal activity. However, the ineffective or slightly effective dose of the selective mu agonist DAGO (1 or 1.5 micrograms, respectively) did not show any synergistic action with clonidine. Furthermore, the synergism between morphine and clonidine was reversed by the selective delta antagonist ICI 174,864. We interpret these results to indicate that opiates interact at spinal delta receptors to produce a synergistic suppression of evoked WDR neuronal activity in the presence of spinal clonidine. An alternative explanation is that ICI 174,864 may interact in some way with alpha-adrenergic systems.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1672579     DOI: 10.1097/00000542-199104000-00018

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  16 in total

1.  The alpha2a adrenergic receptor subtype mediates spinal analgesia evoked by alpha2 agonists and is necessary for spinal adrenergic-opioid synergy.

Authors:  L S Stone; L B MacMillan; K F Kitto; L E Limbird; G L Wilcox
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

2.  Preweanling naltrindole administration differentially affects clonidine induced antinociception and plasma adrenaline levels in male and female neonatal rats.

Authors:  I Alberti; B Fernández; L F Alguacil; A Aguilar; M Caamaño; E M Romero; M P Viveros
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

3.  Low doses of alpha 2-adrenoceptor antagonists augment spinal morphine analgesia and inhibit development of acute and chronic tolerance.

Authors:  B Milne; M Sutak; C M Cahill; K Jhamandas
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739

4.  Oral clonidine reduces postoperative PCA morphine requirements.

Authors:  J Park; J Forrest; R Kolesar; D Bhola; S Beattie; C Chu
Journal:  Can J Anaesth       Date:  1996-09       Impact factor: 5.063

5.  alpha-Adrenoceptor and opioid receptor modulation of clonidine-induced antinociception.

Authors:  F Sierralta; D Naquira; G Pinardi; H F Miranda
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

Review 6.  Spinal opioid systems in inflammation.

Authors:  L Stanfa; A Dickenson
Journal:  Inflamm Res       Date:  1995-06       Impact factor: 4.575

7.  Survey of utilization of medetomidine and atipamezole in private veterinary practice in Quebec in 2002.

Authors:  M Johanna Kaartinen; Sophie Cuvelliez; Line Brouillard; Yves Rondenay; Jean Jacques Kona-Boun; Eric Troncy
Journal:  Can Vet J       Date:  2007-07       Impact factor: 1.008

8.  A leu-enkephalin depresses transmission from muscle and skin non-nociceptors to first-order feline spinal neurones.

Authors:  E Jankowska; E D Schomburg
Journal:  J Physiol       Date:  1998-07-15       Impact factor: 5.182

Review 9.  A review of the physiological effects of alpha2-agonists related to the clinical use of medetomidine in small animal practice.

Authors:  Melissa D Sinclair
Journal:  Can Vet J       Date:  2003-11       Impact factor: 1.008

Review 10.  Pharmacological profiles of alpha 2 adrenergic receptor agonists identified using genetically altered mice and isobolographic analysis.

Authors:  Carolyn A Fairbanks; Laura S Stone; George L Wilcox
Journal:  Pharmacol Ther       Date:  2009-04-23       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.